Colon or semicolon: gut sampling microdevices for omics insights.
Journal
NPJ biofilms and microbiomes
ISSN: 2055-5008
Titre abrégé: NPJ Biofilms Microbiomes
Pays: United States
ID NLM: 101666944
Informations de publication
Date de publication:
02 Oct 2024
02 Oct 2024
Historique:
received:
20
12
2023
accepted:
19
07
2024
medline:
3
10
2024
pubmed:
3
10
2024
entrez:
2
10
2024
Statut:
epublish
Résumé
Ingestible microdevices represent a breakthrough in non-invasive sampling of the human gastrointestinal (GI) tract. By capturing the native spatiotemporal microbiome and intricate biochemical gradients, these devices allow a non-invasive multi-omic access to the unperturbed host-microbiota crosstalk, immune/nutritional landscapes and gut-organ connections. We present the current progress of GI sampling microdevices towards personalized metabolism and fostering collaboration among clinicians, engineers, and data scientists.
Identifiants
pubmed: 39358351
doi: 10.1038/s41522-024-00536-2
pii: 10.1038/s41522-024-00536-2
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
97Informations de copyright
© 2024. The Author(s).
Références
Hickey, J. W. et al. Organization of the human intestine at single-cell resolution. Nature 619, 572–584 (2023).
doi: 10.1038/s41586-023-05915-x
pubmed: 37468586
pmcid: 10356619
Helander, H. F. & Fändriks, L. Surface area of the digestive tract-revisited. Scand. J. Gastroenterol. 49, 681–689 (2014).
doi: 10.3109/00365521.2014.898326
pubmed: 24694282
Labavić, D., Loverdo, C. & Bitbol, A. F. Hydrodynamic flow and concentration gradients in the gut enhance neutral bacterial diversity. Proc. Natl Acad. Sci. USA 119, e2108671119 (2022).
doi: 10.1073/pnas.2108671119
pubmed: 34969835
Chikina, A. & Matic Vignjevic, D. At the right time in the right place: how do luminal gradients position the microbiota along the gut? Cells Dev. 168, 203712 https://doi.org/10.1016/j.cdev.2021.203712 (2021).
De Vos, W. M., Tilg, H., Van Hul, M. & Cani, P. D. Gut microbiome and health: mechanistic insights. Gut 71, 1020–1032 (2022).
doi: 10.1136/gutjnl-2021-326789
pubmed: 35105664
Zilbauer, M. et al. A roadmap for the human gut cell atlas. Nat. Rev. Gastroenterol. Hepatol. 20, 597–614 (2023).
doi: 10.1038/s41575-023-00784-1
pubmed: 37258747
pmcid: 10527367
Levitan, O. et al. The gut microbiome–does stool represent right? Heliyon 9, e13602 (2023).
doi: 10.1016/j.heliyon.2023.e13602
pubmed: 37101508
pmcid: 10123208
Mandsberg, N. K., Christfort, J. F., Kamguyan, K., Boisen, A. & Srivastava, S. K. Orally ingestible medical devices for gut engineering. Adv. Drug Deliv. Rev. 165-166, 142–154, https://doi.org/10.1016/j.addr.2020.05.004 (2020).
doi: 10.1016/j.addr.2020.05.004
pubmed: 32416112
Shalon, D. et al. Profiling the human intestinal environment under physiological conditions. Nature 617, 581–591 (2023).
doi: 10.1038/s41586-023-05989-7
pubmed: 37165188
pmcid: 10191855
Quinn, R. A. et al. Global chemical effects of the microbiome include new bile-acid conjugations. Nature 579, 123–129 (2020).
doi: 10.1038/s41586-020-2047-9
pubmed: 32103176
pmcid: 7252668
Collins, S. L., Stine, J. G., Bisanz, J. E., Okafor, C. D. & Patterson, A. D. Bile acids and the gut microbiota: metabolic interactions and impacts on disease. Nat. Rev. Microbiol. 21, 236–247. https://doi.org/10.1038/s41579-022-00805-x (2023).
Folz, J. et al. Human metabolome variation along the upper intestinal tract. Nat. Metab. 5, 777–788 (2023).
doi: 10.1038/s42255-023-00777-z
pubmed: 37165176
pmcid: 10229427
Wan, Y. et al. Unconjugated and secondary bile acid profiles in response to higher-fat, lower-carbohydrate diet and associated with related gut microbiota: a 6-month randomized controlled-feeding trial. Clin. Nutr. 39, 395–404 (2020).
doi: 10.1016/j.clnu.2019.02.037
pubmed: 30876827
Bisanz, J. E., Upadhyay, V., Turnbaugh, J. A., Ly, K. & Turnbaugh, P. J. Meta-analysis reveals reproducible gut microbiome alterations in response to a high-fat diet. Cell Host Microbe 26, 265–272.e4 (2019).
doi: 10.1016/j.chom.2019.06.013
pubmed: 31324413
pmcid: 6708278
Inagaki, T. et al. Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. Proc. Natl Acad. Sci. USA 103, 3920–3925 (2006).
doi: 10.1073/pnas.0509592103
pubmed: 16473946
pmcid: 1450165
Chen, L., Gruzinskyte, L., Jørgensen, S. L., Boisen, A. & Srivastava, S. K. An ingestible self-polymerizing system for targeted sampling of gut microbiota and biomarkers. ACS Nano 14, 12072–12081 (2020).
doi: 10.1021/acsnano.0c05426
pubmed: 32830478
Rehan, M., Al-Bahadly, I., Thomas, D. G. & Avci, E. Towards gut microbiota sampling using an untethered sampling device. IEEE Access 9, 127175–127184 (2021).
doi: 10.1109/ACCESS.2021.3111086
Waimin, J. F. et al. Smart capsule for non-invasive sampling and studying of the gastrointestinal microbiome. RSC Adv. 10, 16313–16322 (2020).
doi: 10.1039/C9RA10986B
pubmed: 35498852
pmcid: 9052936
Srivastava, S. K., Ajalloueian, F. & Boisen, A. Thread-like radical-polymerization via autonomously propelled (TRAP) bots. Adv. Mater. 31 1901573 (2019).
Rezaei Nejad, H.et al. Ingestible osmotic pill for in vivo sampling of gut microbiomes. Adv. Intell. Syst. 1, 1900053 (2019).
Becker, D. et al. Novel orally swallowable IntelliCap®device to quantify regional drug absorption in human GI tract using diltiazem as model drug. Ageing Int. 15, 1490–1497 (2014).
Mars Incorporated. Sampling device. 1–31 (2014).
Sprenkels A. J. et al. Sampling device for in-vivo sampling of liquids from the gastrointestinal tract, process for the production thereof and mould or mask for use in the production process. 1–30 (2006).
Cui, J. et al. The study of a remote-controlled gastrointestinal drug delivery and sampling system. Telemed. e-Health 14, 715–719 (2008).
doi: 10.1089/tmj.2007.0118
Gu H. H. & Gu H. L. Intestinal fluid sampler. 1–7 (1996).
Rios-Morales, M. et al. A toolbox for the comprehensive analysis of small volume human intestinal samples that can be used with gastrointestinal sampling capsules. Sci. Rep. 11, 8133 (2021).
doi: 10.1038/s41598-021-86980-y
pubmed: 33854074
pmcid: 8046781
Beukema, M., Faas, M. M. & de Vos, P. The effects of different dietary fiber pectin structures on the gastrointestinal immune barrier: impact via gut microbiota and direct effects on immune cells. Exp. Mol. Med. 52, 1364–1376. https://doi.org/10.1038/s12276-020-0449-2 (2020).
Browne, H. P. et al. Culturing of ‘unculturable’ human microbiota reveals novel taxa and extensive sporulation. Nature 533, 543–546 (2016).
doi: 10.1038/nature17645
pubmed: 27144353
pmcid: 4890681
Lagier, J. C. et al. Culturing the human microbiota and culturomics. Nat. Rev. Microbiol. 16, 540–550. https://doi.org/10.1038/s41579-018-0041-0 (2018).
Walker, A. W. & Hoyles, L. Human microbiome myths and misconceptions. Nat. Microbiol. 8, 1392–1396 (2023).
doi: 10.1038/s41564-023-01426-7
pubmed: 37524974
Dworkin, M. Sergei Winogradsky: A founder of modern microbiology and the first microbial ecologist. FEMS Microbiol. Rev. 36, 364–379. https://doi.org/10.1111/j.1574-6976.2011.00299.x (2012).
Esteban, D. J., Hysa, B. & Bartow-McKenney, C. Temporal and spatial distribution of the microbial community of winogradsky columns. PLoS One 10, e0134588 (2015).
doi: 10.1371/journal.pone.0134588
pubmed: 26248298
pmcid: 4527761
Peppercorn, M. A. & Goldman, P. The role of intestinal bacteria in the metabolism of salicylazosulfapyridine. J. Pharmacol. Exp. Ther. 181, 555–562 (1972).
Zheng, D. W.et al. A microbial community cultured in gradient hydrogel for investigating gut microbiome-drug interaction and guiding therapeutic decisions. Adv. Mater. 35, 2300977 (2023).
Zeevi, D. et al. Personalized nutrition by prediction of glycemic responses. Cell 163, 1079–1094 (2015).
doi: 10.1016/j.cell.2015.11.001
pubmed: 26590418
Roelands, J. et al. An integrated tumor, immune and microbiome atlas of colon cancer. Nat. Med. 29, 1273–1286 (2023).
doi: 10.1038/s41591-023-02324-5
pubmed: 37202560
pmcid: 10202816
Ronen, J., Hayat, S. & Akalin, A. Evaluation of colorectal cancer subtypes and cell lines using deep learning. Life Sci. Alliance 2, e201900517 (2019).
doi: 10.26508/lsa.201900517
pubmed: 31792061
pmcid: 6892438
Wang, T. et al. MOGONET integrates multi-omics data using graph convolutional networks allowing patient classification and biomarker identification. Nat. Commun. 12, 3445 (2021).
doi: 10.1038/s41467-021-23774-w
pubmed: 34103512
pmcid: 8187432
Almeida, A. et al. A unified catalog of 204,938 reference genomes from the human gut microbiome. Nat. Biotechnol. 39, 105–114 (2021).
doi: 10.1038/s41587-020-0603-3
pubmed: 32690973
Peterson, J. et al. The NIH human microbiome project. Genome Res. 19, 2317–2323 (2009).
doi: 10.1101/gr.096651.109
pubmed: 19819907
pmcid: 2792171
Proctor, L. et al. The integrative human microbiome project. Nature 569, 623–625 (2019).
doi: 10.1038/d41586-019-01654-0
pubmed: 31142863
Lok, C. Mining the microbial dark matter. Nature 522, 290–273. https://doi.org/10.1038/522270a (2015).
Zamkovaya, T., Foster, J. S., de Crécy-Lagard, V. & Conesa, A. A network approach to elucidate and prioritize microbial dark matter in microbial communities. ISME J. 15, 228–244 (2021).
doi: 10.1038/s41396-020-00777-x
pubmed: 32963345
Bauer, E., Zimmermann, J., Baldini, F., Thiele, I. & Kaleta, C. BacArena: Individual-based metabolic modeling of heterogeneous microbes in complex communities. PLoS Comput. Biol. 13, e1005544 (2017).
doi: 10.1371/journal.pcbi.1005544
pubmed: 28531184
pmcid: 5460873
Dukovski, I. et al. A metabolic modeling platform for the computation of microbial ecosystems in time and space (COMETS). Nat. Protoc. 16, 5030–5082 (2021).
doi: 10.1038/s41596-021-00593-3
pubmed: 34635859
pmcid: 10824140
Louca, S. & Doebeli, M. Calibration and analysis of genome-based models for microbial ecology. Elife 4, e08208 (2015).
Altay, O., Nielsen, J., Uhlen, M., Boren, J. & Mardinoglu, A. Systems biology perspective for studying the gut microbiota in human physiology and liver diseases. EBioMedicine 49, 364–373. https://doi.org/10.1016/j.ebiom.2019.09.057 (2019).
Lin, C. et al. GutLogo: agent-based modeling framework to investigate spatial and temporal dynamics in the gut microbiome. PLoS One 13, e0207072 (2018).
doi: 10.1371/journal.pone.0207072
pubmed: 30412640
pmcid: 6226173
Mirzayi, C. et al. Reporting guidelines for human microbiome research: the STORMS checklist. Nat. Med. 27, 1885–1892. https://doi.org/10.1038/s41591-021-01552-x (2021).
Dhakan, D. B.et al. The unique composition of Indian gut microbiome, gene catalogue, and associated fecal metabolome deciphered using multi-omics approaches. Gigascience 8, giz004 (2019).
Huey, S. L.et al. Nutrition and the gut microbiota in 10- to 18-month-old children living in urban slums of Mumbai, India. mSphere 5, e00731-20 (2020).
Anjana, R. M. et al. Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17). Lancet Diabetes Endocrinol. 11, P474–489 (2023).
doi: 10.1016/S2213-8587(23)00119-5